Efficient access to polysubstituted tetrahydrofurans by electrophilic cyclization of vinylsilyl alcohols

Asunción Barbero*a, Héctor Barberob, Alfonso González-Ortegaa, Francisco J. Pulidoa, Patricia Vala, Alberto Diez-Vargaa and Joaquín R. Moránc
aDepartment of Organic Chemistry, University of Valladolid, Campus Miguel Delibes, 47011 Valladolid, Spain. E-mail: barbero@qo.uva.es
bDepartment of Chemical Physics and Inorganic Chemistry, Campus Miguel Delibes, 47011 Valladolid, Spain
cDepartment of Organic Chemistry, University of Salamanca, Plaza de los Caídos, 1-5, E-37008, Salamanca, Spain

Received 13th April 2015 , Accepted 27th May 2015

First published on 28th May 2015


Abstract

Vinylsilyl alcohols undergo intramolecular cyclization to provide di-, tri- or tetrasubstituted-tetrahydrofurans. The influence of the number and position of substituents in the stereoselectivity of the process has been studied. Moreover, DFT calculations have been performed to get better insight into the influence of the substitution pattern of the vinylsilyl alcohol in the stereoselectivity of the cyclization.


Introduction

Five-membered oxacycles are abundant in several polycyclic and monocyclic natural bioactive products. Within them, the family of polyketide macrolides has emerged as a challenge for organic chemists. Most known macrolides contain THP rings in their structure or an array of THP and THF rings. However, lately there have been described several THF-containing macrolides with important therapeutic properties.1

For example, natural polyketide macrolides containing tetrahydrofuranyl moieties include nonactin,2 ionophoric antibiotic isolated from the Streptomyces, chagosensine,3 chlorinated macrolide isolated from the Red Sea calcareous sponge Leucetta chagosensis, amphidinolactone B,4 cytotoxic macrolide isolated from the marine dinoflagellate Amphidinium sp. or phormidolide,5 toxic metabolite isolated from the marine cyanobacterium Phormidium sp., within others (Fig. 1).


image file: c5ra06640a-f1.tif
Fig. 1 Polyketide macrolides containing tetrahydrofuranyl moieties.

Numerous researchers have been attracted by the molecular complexity, stereochemical diversity and potential pharmacological properties of such systems. Particular attention has emerged towards the synthesis of substituted tetrahydrofurans, which are common structural features present in these natural products. The construction of such structures has been accomplished using a variety of methods. A powerful approach is the electrophilic cyclization of alkenes bearing a nucleophile. Different electrophilic sources have been reported, such as halogen,6 selenium7 or mercury.8 The cyclization has shown to be dependent on the nature of the electrophile and steric and electronic factors. In most cases, the process affords a mixture of both possible stereoisomers, although one of them is usually obtained as the major one.

However, few successful examples have been reported on the acid-mediated cyclization of alkenols. Recently, Hosomi et al. have described the synthesis of disubstituted tetrahydrofurans by acid-catalyzed cyclization of vinylsilanes, comparing the behaviour of different silyl groups.9

On the other hand, while most of these synthetic methods deal with the synthesis of 2,5-disubstituted tetrahydrofurans, many of the 5-membered oxacycles found in natural macrolides are 2,3,5-tri- or 2,2,3,5-tetrasubstituted.

As part of our studies on the synthetic applications of allyl- and vinylsilanes towards the construction of different sized carbo-10 and heterocycles,11 we have recently published the intramolecular cyclization of allylsilyl alcohols to give silylated tetrahydrofurans in good yield.12

We now present ours results on the cyclization of vinylsilyl alcohols, bearing the phenyldimethylsilyl group, to give di-, tri- and tetrasubstituted tetrahydrofurans in a stereoselective manner.

Results and discussion

The vinylsilyl alcohols needed for this study were readily prepared in two steps, with an initial silylcupration of alkynes followed by reaction with α,β-unsaturated carbonyl compounds to give oxovinylsilanes 1a–k. The subsequent reduction with LiAlH4 afforded the desired alcohols in nearly quantitative yields. The reduction of compounds 1h–i, k provided an equimolar mixture of diastereoisomers 2h–i, k and 3h–i, k which could be separated by chromatography (Table 1).
Table 1 Synthesis of vinylsilyl alcohols

image file: c5ra06640a-u1.tif

Entry Compound Ratio 2/3 Yield (%)
R1 R2 R3 R4  
1 H H H H 2a   93
2 H Me H H 2b   90
3 H Pr H H 2c   92
4 H Ph H H 2d   89
5 Me H H H 2e   94
6 Et H H H 2f   91
7 Me Me Me H 2g   90
8 Me Ph H H 2h/3h 50[thin space (1/6-em)]:[thin space (1/6-em)]50 88
9 Me iPr H H 2i/3i 50[thin space (1/6-em)]:[thin space (1/6-em)]50 92
10 H Ph H Ph 2j   89
11 Ph Ph H Ph 2k/3k 50[thin space (1/6-em)]:[thin space (1/6-em)]50 90


We used vinylsilyl alcohol 2g as a model substrate and subjected it to cyclization using both acidic conditions (p-TsOH) and mercury-cyclization. The results are shown in Table 2.

Table 2 Cyclization of vinylsilyl alcohol 2g

image file: c5ra06640a-u2.tif

Entry Reagent Temp/°C Time/h Ratioa 4[thin space (1/6-em)]:[thin space (1/6-em)]5 Yield (%)
a The ratio of isomers 4 and 5 were determined by 1H-NMR analysis.b The reaction rate was very slow at 0 °C. A great amount of starting alcohol was recovered.
1 Hg(OTFA)2 −40 → 0 25 80[thin space (1/6-em)]:[thin space (1/6-em)]20 83
2 p-TsOH 0 25 85[thin space (1/6-em)]:[thin space (1/6-em)]15 49b
3 p-TsOH r. t. 10 84[thin space (1/6-em)]:[thin space (1/6-em)]16 90
4 p-TsOH 40 3 75[thin space (1/6-em)]:[thin space (1/6-em)]25 92


From the results shown in Table 2 we can conclude that the stereoselectivity of the acid-catalyzed cyclization is moderate and dependent on the temperature of the reaction. Thus, a decrease in the temperature causes an increase in the dr of the cyclization, obtaining the best results when the reaction is conducted at room temperature. Lowering the temperature to 0 °C caused a remarkable decrease in the reaction rate, and after 25 hours of reaction a great amount of starting alcohol could be detected in the reaction mixture. Slightly lower stereoselectivities, together with longer reaction times, are obtained in the mercury-cyclization. In all cases the major stereoisomer is always the 2,5-trans tetrahydrofuran.

Next, we examined the scope of this cyclization using different vinylsilyl alcohols, in order to examine the influence of the substitution in the stereoselectivity of the process. The results are shown in Table 3.

Table 3 Scope of the cyclization of vinylsilyl alcohols

image file: c5ra06640a-u3.tif

Entry Compound Reagent Temp/°C Time/h Ratioa 4[thin space (1/6-em)]:[thin space (1/6-em)]5 Yield (%)
R1 R2 R3  
a The ratio of isomers 4 and 5 were determined by 1H-NMR analysis.b Reaction conditions: mercury salt (1.09 mmol), CaCO3 (2.17 mmol), vinylsilyl alcohol (1 mmol), solvent THF.
1 H H H 2a p-TsOH 40 3   92
2 H Me H 2b Hg(OTFA)2 r. t. 24 >95[thin space (1/6-em)]:[thin space (1/6-em)]5 89b
3 H Me H 2b Hg(OAc)2 r. t. 24 >95[thin space (1/6-em)]:[thin space (1/6-em)]5 90b
4 H Me H 2b p-TsOH 40 15 >95[thin space (1/6-em)]:[thin space (1/6-em)]5 89
5 H Pr H 2c p-TsOH 40 15 >95[thin space (1/6-em)]:[thin space (1/6-em)]5 80
6 H Ph H 2d p-TsOH 40 16 >95[thin space (1/6-em)]:[thin space (1/6-em)]5 82
7 Me H H 2e p-TsOH 40 5 80[thin space (1/6-em)]:[thin space (1/6-em)]20 89
8 Me H H 2e p-TsOH r. t. 12 89[thin space (1/6-em)]:[thin space (1/6-em)]11 80
9 Et H H 2f p-TsOH 40 4 72[thin space (1/6-em)]:[thin space (1/6-em)]28 87
10 Me Me Me 2g p-TsOH 40 3 75[thin space (1/6-em)]:[thin space (1/6-em)]25 92
11 Me Me Me 2g p-TsOH r. t. 10 84[thin space (1/6-em)]:[thin space (1/6-em)]16 90


As illustrated in Table 3, the cyclization of vinylsilyl alcohols with allylic substituents 2b–d (R1 = H, R2 ≠ H) led to a unique 2,3-trans-disubstituted tetrahydrofuran, both using the acid-catalyzed or the mercury cyclization and independently of the bulkiness of the substituent (Table 3, entries 2–6). However, the mercury-cyclization is slower than the acid-catalyzed one (Table 3, entries 2–4). In contrast, cyclization of vinylsilanes 2e–2g with an alkyl group on the carbon bounded to the hydroxy group (R1 ≠ H, R2 = R3) afforded substituted tetrahydrofurans with moderate 2,5-trans stereoselectivity (Table 3, entries 7–11). As it is shown (entries 7–8, 10–11) the effect of the temperature on the stereoselectivity of the process is well defined. Thus, the best stereoselectivity for cyclization of alcohol 2e and 2g was found when the reaction was performed at room temperature.

We next decided to study the cyclization of vinylsilyl alcohols bearing both types of substituents (one on the allylic position and the other on the carbon bounded to the hydroxy group). The results are shown in Scheme 1.


image file: c5ra06640a-s1.tif
Scheme 1 Stereoselective synthesis of 2,3,5-trisubstituted tetrahydrofurans.

Interestingly, the cyclization of those substrates proceeds with excellent diastereocontrol (only one diastereoisomer could be detected in the reaction mixture), which seems to indicate that the influence of the allylic group (R2) on the stereoselectivity is greater than that of the R1 substituent. Moreover, the use of two diastereomeric vinylsilyl alcohols 2h–i and 3h–i allowed us to conclude that the allylic substituent is the one that controls the stereochemical outcome of the process since the final tetrahydrofurans always have the 2,3-trans-configuration.

Finally, we decided to study the cyclization of vinylsilyl alcohols bearing an additional substituent β to silicon. The results are shown in Scheme 2.


image file: c5ra06640a-s2.tif
Scheme 2 Synthesis of 2,2,3,5-tetrasubstituted tetrahydrofurans.

Surprisingly, this time the cyclization in the presence of p-TsOH is not stereoselective, affording an almost equimolar mixture of both diastereoisomeric tetrahydrofurans. Probably the presence of an extra substituent β to silicon will cause an unfavourable steric effect which will account for the shown loss of stereoselectivity.

On the other hand, it has been reported that α-alkylsubstituted vinylsilanes undergo 1-2-silyl migration when subjected to acid-catalyzed cyclization to give silylated tetrahydropyrans.13 In contrast, our β-substituted vinylsilanes 2j–k, 3k do not follow this pattern, probably due to the fact that such migration would lead to a very unstable primary carbocation.14

Mechanistic proposal

Following the models proposed by Houk15 and Fleming16 for the electrophilic attack on alkenes bearing an allylic stereogenic center, we could draw two chair-like reactive conformations for the cyclization of vinylsilyl alcohols 2b–d. In the preferred conformation A, the largest substituent is antiperiplanar to the double bond, and the smallest allylic substituent (H) is located in the inside position. In the other possible conformation B, with R2 inside, a severe 1,3-allylic steric interaction between R2 and the silyl group can be seen which would explain the large preference for cyclization via conformer A (Fig. 2).
image file: c5ra06640a-f2.tif
Fig. 2 Chair-like reactive conformations for alcohols 2b–d.

Regarding the acid-catalyzed reaction, and in accordance with Hosomi's mechanistical proposal,9b the reaction would then proceed through an initial acid–base reaction to give an oxonium ion which would undergo proton transfer leading to a stabilized β-carbocation to silicon (through rotation of the C–Si bond in order to be parallel to the empty p orbital). Final syn-addition of the hydroxy group would lead to the silylated tetrahydrofuran (Fig. 2).

On the other hand, it's known that the corresponding electrophilic mercury cyclization should occur in an anti-fashion. In this case, starting from preferred conformation A, the electrophilic attack would occur anti to the largest group to provide the corresponding mercuronium ion. The following intramolecular addition of the alcohol would provide the observed 2,3-trans-tetrahydrofuran 4b (Fig. 3).


image file: c5ra06640a-f3.tif
Fig. 3 Mechanism for the mercury-cyclization of alcohol 2b.

Similarly, the moderate stereoselectivity observed in the acid-catalyzed cyclization of vinylsilyl alcohols 2e–f, would indicate a small energy difference between conformers C and D in favour of conformation C. Thus, conformer D possesses a repulsive interaction between groups R1 and SiR3 on a 1,3-pseudoaxial orientation. As a result cyclization of C would proceed faster than that of conformer D, leading to a major trans-2,5-tetrahydrofuran (Fig. 4).


image file: c5ra06640a-f4.tif
Fig. 4 Chair-like reactive conformations for alcohols 2e–f.

In addition, the loss of stereocontrol observed for the cyclization of vinylsilyl alcohols with a substituent R4 β to silicon 2j, k, 3k can be again explained using Houk and Fleming's models since now, apart from the 1,3-allylic strain, there is a competing disfavouring interaction which is the 1,2-allylic strain between R2 and R4 (Fig. 5).


image file: c5ra06640a-f5.tif
Fig. 5 Chair-like reactive conformations for alcohols 2j, k, 3k.

In order to get further insight into the substitution effect observed in the stereoselectivity of these reactions DFT calculations were conducted. The calculations were performed using compounds 2b and 2e as models for vinylsilyl alcohol with or without allylic substituents.17 Calculations were initiated for compound 2b. The two different reaction pathways leading to the corresponding 2,3-trans tetrahydrofuran 4b and 2,3-cis tetrahydrofuran 5b have been drawn, starting from the stabilized β-silylcarbocation (Fig. 6).


image file: c5ra06640a-f6.tif
Fig. 6 Reaction pathways for the formation of 4b and 5b.

As shown, intermediate II is more stable than I by 1.46 kcal mol−1 and the activation energy of TSI is 3.08 kcal mol−1 higher than that of TSII (Table 4), which indicates that the cyclization through path b is kinetically more favorable than through path a. Moreover, the protonated tetrahydrofurans III and IV are similar in energy, but the final tetrahydrofuran 4b is significantly more stable than 5b in thermodynamics (by 3.5 kcal mol−1). Overall, the shown calculations are in agreement with the high stereoselectivity towards 4b observed when the vinylsilyl alcohol 2b, with an allylic substituent, is submitted to cyclization.

Table 4 Free energies for the cyclization of 2b
Pathway ΔG≠ (kcal mol−1) ΔGreaction1 (kcal mol−1) ΔGreaction2a (kcal mol−1)
a Calculated from structures III and IV to 5b and 4b, respectively.
a 5.30 −3.19 −28.77
b 2.22 −4.92 −31.90


Moreover, optimization of structures I and II give us additional information relative to the influence of the allylic substituent in the stereoselectivity of this cyclization. Thus, the optimized structure for II, which corresponds to the stabilized β to silicon cation of conformation A with H inside, shows a boat-like conformation where the intermediate carbocation is easily accessible by the OH group. However, the optimized structure for I, with Me inside, is a quasi linear conformation in which the OH group is far apart from the carbocation atom (Fig. 6).18 This means that in order to be able to cyclize, structure I has to rotate to get a suitable orientation between the reactive groups, which in consequence will require a higher energy.

Moreover, the calculated Boltzmann distribution for TSI and TSII correlate perfectly with the experimental ratio obtained in the cyclization for tetrahydrofurans 4b and 5b (Table 5).

Table 5 Estimated Boltzmann distribution in solution at room temperature for TSI and TSII
Transition state ΔG/kbT % Distribution (25 °C) % Experimental ratio
TSII 0.00 92.1 >95
TSI 2.46 7.9 <5


Noteworthy, calculations for compound 2e reveal several differences (Fig. 7). Now tetrahydrofurans 4e and 5e have almost the same energy (being 4e 0.24 kcal mol−1 more stable than 5e). Moreover, protonated furans VII and VIII are close in energy (being VIII 2.514 kcal mol−1 more stable) and a similar trend is observed for structures V and VI, which have a difference in energy of 1.08 kcal mol−1. In addition, the free energy barriers for both pathways only differ in 0.03 kcal mol−1 (Table 6). On the basis of these computational studies we can conclude that although path d is more favorable than path c, the difference in their energy profiles makes feasible the obtention of mixtures of both stereoisomers.


image file: c5ra06640a-f7.tif
Fig. 7 Reaction pathways for the formation of 4e and 5e.
Table 6 Free energies for the cyclization of 2e
Pathway ΔG≠ (kcal mol−1) ΔGreaction1 (kcal mol−1) ΔGreaction2a (kcal mol−1)
a Calculated from structures VII and VIII to 5e and 4e, respectively.
c 3.18 −4.38 −28.53
d 3.15 −6.89 −27.34


The observation of the corresponding optimized structures V and VI is also in agreement with this conclusion. Thus, the optimization without restrictions of these structures show that the preferred conformation for V and VI are essentially extended zig-zag conformations. Neither of these conformations is appropriate for cyclization, suggesting a moderate preference for either path c or d (Fig. 7).

Again, the estimated Boltzmann distribution for TSIV and TSIII (Table 7) is consistent with the experimental results (Table 3, entry 7).

Table 7 Estimated Boltzmann distribution in solution at room temperature for TSIV and TSIII
Transition state ΔG/kbT % Distribution (25 °C) % Experimental ratio
TSIV 0.00 86.7 89
TSIII 1.83 13.3 11


Finally, we decided to study the behaviour of a vinylsilyl alcohol 2h with two substituents (R1 ≠ H, R2 ≠ H) on the alkylic chain. As depicted in Fig. 8, the predicted lower energy pathway f is consistent with the experimental results (Scheme 1). These results confirm unambiguously the great influence of the allylic substituent in the stereocontrol of this process. The difference in energy between intermediate IX, which is the corresponding carbocation from B with R2 = Ph inside (Fig. 2), and X, with H inside, is 4.66 kcal mol−1 and between the predicted barriers for TSV and TSVI is 4.56 kcal mol−1 (Table 8), favouring the formation of tetrahydrofuran 4h. As shown in TSV, the bulky phenyl group is blocking the approach of the hydroxy group to the reactive alkene moiety, which is consistent with the high energy barrier for pathway e.


image file: c5ra06640a-f8.tif
Fig. 8 Reaction pathways for the formation of 4h and 5h.
Table 8 Free energies for the cyclization of 2h
Pathway ΔG≠ (kcal mol−1) ΔGreaction1 (kcal mol−1) ΔGreaction2 (kcal mol−1)
e 7.60 −5.42 −32.98
f 3.04 −5.79 −28.85


Finally, the calculate Boltzmann distribution for TSVI and TSV (Table 9) are also consistent with the experimental obtention of a unique diastereoisomer 4h (Scheme 1).

Table 9 Estimated Boltzmann distribution in solution at room temperature for TSVI and TSV
Transition state ΔG/kbT % Distribution (25 °C) % Experimental ratio
TSVI 0.00 99.99 >95
TSV 1.83 0.001 <5


Conclusions

In conclusion, we have described an efficient and stereoselective synthesis of di-, tri- and tetrasubstituted tetrahydrofurans through the intramolecular cyclization of vinylsilyl alcohols. This methodology is a general approach to the synthesis of a wide range of tetrahydrofurans bearing substituents on C-2, C-3 or C-5, which represent the most frequent structures in the framework of many natural oxacycles. Moreover, the presence of the silyl group in the substrate provides an easy entry to further functionalization, due to the ability of silicon to be oxidized under mild conditions (Fleming–Tamao oxidation).

Experimental

General experimental

All the reactions were carried out under an atmosphere of argon or nitrogen in dried glassware unless otherwise indicated. Materials were obtained from commercial suppliers and used without further purification except when otherwise noted. Solvents were dried and distilled according to the standard protocols. Flash column chromatography was performed on silica gel using the indicated solvent.

Synthesis of vinylsilyl aldehydes or ketones 1a–k

To a stirred suspension of CuCN (6 mmol) in dry THF (10 ml), under nitrogen, was added a solution of PhMe2SiLi (6 mmol) and the mixture stirred for 30 min. at 0 °C. The solution was then cooled to −78 °C and the acetylene (6 mmol) was added and stirred for an additional hour. BF3·OEt2 (6 mmol) or TMSCl (6 mmol) was then added and, after 5 min stirring at −78 °C, the α,β-unsaturated carbonyl compound (7 mmol) was added dropwise. The resulting mixture was allowed to warm to 0 °C, quenched with basic saturated ammonium chloride solution (15 ml) and extracted with ether (3 × 15 ml). The organic layer was dried over MgSO4 and the solvent rotoevaporated. Purification by flash chromatography gave the vinylsilyl aldehydes or ketones 1a–k. The synthesis and spectroscopic data of vinylsilyl ketones 1e, f, h, i have been previously described.11a
(Z)-5-Dimethylphenylsilyl-4-pentenal (1a). Colorless oil (87%); IR νmax(film)/cm−1 1728, 1605, 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 9.62 (s, 1H), 7.60–7.52 (m, 2H), 7.40–7.36 (m, 3H), 6.44–6.34 (m, 1H), 5.76 (d, J = 14.0 Hz, 1H), 2.39–2.36 (m, 4H), 0.42 (s, 6H, (CH3)2Si); 13C NMR (75 MHz, CDCl3) δ = 201.5 (CHO), 147.7 (CH), 139.2 (C), 133.6 (CH), 129.0 (CH), 128.9 (CH), 127.8 (CH), 43.3 (CH2), 26.1 (CH2), −1.1 (CH3); MS (CI): m/z 219 (M+ + 1), 203 (M+ − Me), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C13H18NaOSi ([M + Na]+): 241.1019, found 241.1024.
(Z)-5-Dimethylphenylsilyl-3-methyl-4-pentenal (1b). Colorless oil (85%); IR νmax(film)/cm−1 1724, 1605, 1249, 1113; 1H NMR (300 MHz, CDCl3) δ = 9.44 (s, 1H), 7.62–7.56 (m, 2H), 7.41–7.35 (m, 3H), 6.23 (dd, J = 14.0 and 10.1 Hz, 1H), 5.71 (d, J = 14.0 Hz, 1H), 2.89–2.79 (m, 1H), 2.30–2.21 (m, 2H), 0.98 (d, J = 6.6 Hz, 3H), 0.48 (s, 3H, CH3Si), 0.46 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 201.6 (CHO), 153.5 (CH), 139.2 (C), 133.7 (CH), 129.1 (CH), 127.9 (CH), 126.8 (CH), 50.3 (CH2), 33.0 (CH), 20.6 (CH3), −0.9 (CH3), −1.1 (CH3); MS (CI): m/z 233 (M+ + 1), 217 (M+ − Me), 155 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C14H20NaOSi ([M + Na]+): 255.1176, found 255.1181.
(Z)-5-Dimethylphenylsilyl-3-propyl-4-pentenal (1c). Colorless oil (79%); IR νmax(film)/cm−1 1724, 1605, 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 9.40 (t, J = 2.4 Hz, 1H), 7.61–7.53 (m, 2H), 7.43–7.38 (m, 3H), 6.17 (dd, J = 14.0 and 10.1 Hz, 1H), 5.74 (d, J = 14.0 Hz, 1H), 2.74–2.62 (m, 1H), 2.32 (ddd, J = 15.8, 6.6 and 2.4 Hz 1H), 2.15 (ddd, J = 15.8, 7.0 and 2.4 Hz, 1H), 1.41–1.15 (m, 4H), 0.85 (t, J = 6.6 Hz, 3H), 0.47 (s, 3H, CH3Si), 0.44 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 201.8 (CHO), 152.6 (CH), 139.2 (C), 133.7 (CH), 129.0 (CH), 128.0 (CH), 127.8 (CH), 48.9 (CH2), 37.9 (CH), 37.3 (CH2), 20.2 (CH2), 14.1 (CH3), −1.0 (CH3), −1.2 (CH3); MS (CI): m/z 261 (M+ + 1), 245 (M+ − Me), 183 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C16H24NaOSi ([M + Na]+): 283.1489, found 283.1491.
(Z)-5-Dimethylphenylsilyl-3-phenyl-4-pentenal (1d). Colorless oil (83%); IR νmax(film)/cm−1 1721, 1595, 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 9.44 (t, J = 2.0 Hz, 1H), 7.66–7.62 (m, 2H), 7.49–7.42 (m, 3H), 7.34–7.21 (m, 3H), 7.09–7.02 (m, 2H), 6.56 (dd, J = 14.0 and 10.3 Hz, 1H), 5.82 (d, J = 14.0 Hz, 1H), 4.09–3.95 (m, 1H), 2.78 (ddd, J = 16.2, 7.9 and 2.0 Hz, 1H), 2.57 (ddd, J = 16.2, 7.0 and 2.0 Hz, 1H), 0.44 (s, 6H, (CH3)2Si); 13C NMR (75 MHz, CDCl3) δ = 200.8 (CHO), 150.7 (CH), 142.3 (C), 138.9 (C), 133.9 (CH), 129.2 (CH), 128.7 (CH), 128.2 (CH), 128.0 (CH), 127.1 (CH), 126.6 (CH), 49.7 (CH2), 43.3 (CH), −1.0 (CH3), −1.2 (CH3); MS (CI): m/z 293 (M+ − 1), 279 (M+ − Me), 217 (M+ − Ph), 135 (SiMe2Ph).
(Z)-6-Dimethylphenylsilyl-4,4-dimethyl-5-hexen-2-one (1g). Colorless oil (87%); IR νmax(film)/cm−1 1716, 1595, 1249, 1111; 1H NMR (300 MHz, CDCl3) δ = 7.55–7.53 (m, 2H), 7.35–7.32 (m, 3H), 6.53 (d, J = 15.7 Hz, 1H), 5.63 (d, J = 15.7 Hz, 1H), 2.33 (s, 2H), 1.97 (s, 3H), 1.04 (s, 6H), 0.42 (s, 6H, (CH3)2Si); 13C NMR (75 MHz, CDCl3) δ = 208.2 (CO), 159.6 (CH), 140.8 (C), 134.1 (CH), 129.2 (CH), 128.1 (CH), 124.8 (CH), 55.9 (CH2), 38.4 (C), 32.2 (CH3), 28.2 (2 × CH3), 0.98 (2 × CH3); MS (CI): m/z 261 (M+ + 1), 245 (M+ − Me), 183 (M+ − Ph), 135 (SiMe2Ph).
(E)-5-Dimethylphenylsilyl-3,4-diphenyl-4-pentenal (1j). Colorless oil (89%); IR νmax(film)/cm−1 1728, 1249, 1110; 1H NMR (300 MHz, CDCl3) δ = 9.32 (s, 1H), 7.70–7.67 (m, 2H), 7.42–7.41 (m, 3H), 7.27–7.14 (m, 6H), 7.05–7.03 (m, 2H), 6.82–6.80 (m, 2H), 5.94 (s, 1H), 4.64 (dd, J = 8.8 and 6.6 Hz, 1H), 2.89 (dd, J = 16.7 and 8.8 Hz, 1H), 2.54 (dd, J = 16.7 and 6.6 Hz, 1H), 0.62 (s, 3H), 0.56 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 201.4 (CH), 160.0 (C), 142.7 (C), 140.3 (C), 139.2 (C), 134.1 (CH), 130.8 (CH), 129.5 (CH), 128.6 (CH), 128.3 (CH), 128.2 (CH), 127.8 (CH), 127.4 (CH), 126.9 (CH), 46.3 (CH2), 44.8 (CH), −0.5 (CH3), −1.0 (CH3); MS (CI) m/z (%) 371 (M+ + 1), 370 (M+), 369 (M+ − 1), 355 (M+ − Me), 341 (M+ − CHO), 293 (M+ − Ph), 235 (M+ − SiMe2Ph), 135 (SiMe2Ph).
(E)-5-Dimethylphenylsilyl-1,3,4-triphenyl-4-penten-1-one (1k). Colorless oil (82%); IR νmax(film)/cm−1 1680, 1260, 1110; 1H NMR (300 MHz, CDCl3) δ = 7.84–6.91 (m, 20H), 5.96 (s, 1H), 5.12 (dd, J = 8.7 and 5.1 Hz, 1H) 3.65 (dd, J = 17.4 and 8.7 Hz, 1H) (m, 1H), 3.18 (dd, J = 17.4 and 5.1 Hz, 1H), 0.61 (s, 3H, CH3Si), 0.58 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 197.6 (C), 160.1 (C), 143.4 (C), 141.3 (C), 139.3 (C), 137.1 (C), 134.0 (CH), 133.0 (CH), 130.5 (CH), 129.0 (CH), 128.5 (CH), 128.2 (CH), 128.1 (CH), 128.0 (CH), 127.9 (CH), 127.7 (CH), 127.6 (CH), 127.1 (CH), 126.2 (CH), 45.4 (CH), 41.5 (CH2), −0.9 (CH3), −1.1 (CH3).

Synthesis of vinylsilyl alcohols 2 and 3

To a suspension of 1.7 mmol of LiAlH4 in dry ether (8 ml), under nitrogen, was added a solution of the vinylsilyl aldehydes or ketones 1a–k (2 mmol) in dry ether (2 ml) at 0 °C. The mixture was stirred for 45 min at 0 °C and then quenched with 4 ml of NaHCO3 (10%) and 4 ml of NaOH (20%). The organic layer was dried, the solvent evaporated and the mixture was purified by flash chromatography (EtOAc/hexane 1[thin space (1/6-em)]:[thin space (1/6-em)]10) to give alcohols 2 and 3. The spectroscopic data of vinylsilyl alcohol 2d has been previously described.9b
(Z)-5-Dimethylphenylsilyl-4-penten-1-ol (2a). Colorless oil (93%); IR νmax(film)/cm−1 3331, 1605, 1249, 1106; 1H NMR (300 MHz, CDCl3) δ = 7.69–7.59 (m, 2H), 7.48–7.41 (m, 3H), 6.55–6.46 (m, 1H), 5.77 (d, J = 14.0 Hz, 1H), 3.51 (t, J = 6.6 Hz, 2H), 2.18 (q, J = 7.5 Hz, 2H), 2.11–2.09 (br s, 1H, OH), 1.65–1.52 (m, 2H), 0.47 (s, 6H, (CH3)2Si); 13C NMR (75 MHz, CDCl3) δ = 150.1 (CH), 139.7 (C), 133.8 (CH), 129.0 (CH), 127.9 (CH), 127.5 (CH), 62.1 (CH2), 32.4 (CH2), 30.1 (CH2), −0.8 (CH3); MS (CI): m/z 219 (M+ − 1), 205 (M+ − Me), 142 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C13H20NaOSi ([M + Na]+): 243.1176, found 243.1178.
(Z)-5-Dimethylphenylsilyl-3-methyl-4-penten-1-ol (2b). Colorless oil (90%); IR νmax(film)/cm−1 3331, 1605, 1249, 1113; 1H NMR (300 MHz, CDCl3) δ = 7.68–7.62 (m, 2H), 7.44–7.40 (m, 3H), 6.24 (dd, J = 14.0 and 10.1 Hz, 1H), 5.70 (d J = 14.0 Hz, 1H), 3.51–3.37 (m, 2H), 2.48–2.34 (m, 1H), 1.78 (s, 1H, OH), 1.59–1.40 (m, 2H), 0.97 (d, J = 6.6 Hz, 3H), 0.49 (s, 3H, CH3Si), 0.46 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 156.2 (CH), 139.8 (C), 133.7 (CH), 129.0 (CH), 127.9 (CH), 125.8 (CH), 60.9 (CH2), 39.8 (CH2), 34.9 (CH), 21.0 (CH3), −0.6 (CH3), −1.0 (CH3); MS (CI): m/z 219 (M+ − Me), 157 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C13H18NaOSi ([M + Na]+): 257.1332, found 257.1330.
(Z)-5-Dimethylphenylsilyl-3-propyl-4-penten-1-ol (2c). Colorless oil (92%); IR νmax(film)/cm−1 3331, 1605, 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.61–7.58 (m, 2H), 7.40–7.38 (m, 3H), 6.15 (dd, J = 14.0 and 10.1 Hz, 1H), 5.69 (d, J = 14.0 Hz, 1H), 3.50–3.35 (m, 2H), 2.28–2.17 (m, 1H), 1.63–1.52 (m, 1H), 1.41–1.14 (m, 6H), 0.85 (t, J = 6.6 Hz, 3H), 0.45 (s, 3H, CH3Si), 0.41 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 155.2 (CH), 139.8 (C), 133.8 (CH), 129.0 (CH), 127.8 (CH), 126.8 (CH), 61.0 (CH2), 40.0 (CH), 37.9 (CH2), 37.8 (CH2), 20.2 (CH2), 14.4 (CH3), −0.7 (CH3), −0.9 (CH3); MS (CI): m/z 261 (M+ − 1), 247 (M+ − Me), 185 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C16H26NaOSi ([M + Na]+): 285.1645, found 285.1642.
(Z)-6-Dimethylphenylsilyl-5-hexen-2-ol (2e). Colorless oil (94%); IR νmax(film)/cm−1 3360, 1605, 1249, 1112; 1H NMR (300 MHz, CDCl3) δ = 7.57–7.55 (m, 2H), 7.36–7.34 (m, 3H), 6.50 (dt, J = 14.3 and 7.4 Hz, 1H), 5.74 (dd, J = 14.3 and 1.1 Hz, 1H), 3.73–3.61 (m, 1H), 2.23–2.09 (m, 2H), 1.80 (br s, 1H), 1.55–1.40 (m, 2H), 1.07 (d, J = 6.3 Hz, 3H), 0.46 (s, 3H, CH3Si), 0.44 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 152.5 (CH), 140.0 (C), 133.8 (CH), 129.4 (CH), 128.2 (CH), 128.0 (CH), 67.9 (CH), 39.2 (CH2), 30.2 (CH2), 23.9 (CH3), −0.5 (CH3), −0.6 (CH3); MS (CI): m/z 233 (M+ − 1), 219 (M+ − Me), 157 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C14H22NaOSi ([M + Na]+): 257.1332, found 257.1331.
(Z)-7-Dimethylphenylsilyl-6-hepten-3-ol (2f). Colorless oil (91%); IR νmax(film)/cm−1 3402, 1605, 1248, 1112; 1H NMR (300 MHz, CDCl3) δ = 7.57–7.53 (m, 2H), 7.37–7.32 (m, 3H), 6.43 (dt, J = 14.0 and 7.0 Hz, 1H), 5.68 (d, J = 14.0 Hz, 1H), 3.40–3.30 (m, 1H), 2.20–2.08 (m, 2H), 1.42–1.27 (m, 4H), 1.27 (br s, 1H), 0.83 (t, J = 7.0 Hz, 3H), 0.41 (s, 3H, CH3Si), 0.40 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 150.5 (CH), 139.9 (C), 133.9 (CH), 129.1 (CH), 128.0 (CH), 127.5 (CH), 72.9 (CH), 36.6 (CH2), 30.2 (CH2), 30.1 (CH2), 10.0 (CH3), −0.7 (CH3), −0.8 (CH3); MS (CI): m/z 247 (M+ − 1), 171 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C15H24NaOSi ([M + Na]+): 271.1489, found 271.1490.
(Z)-6-Dimethylphenylsilyl-4,4-dimethyl-5-hexen-2-ol (2g). Colorless oil (90%); IR νmax(film)/cm−1 3397, 1605, 1248, 1111; 1H NMR (300 MHz, CDCl3) δ = 7.62–7.58 (m, 2H), 7.40–7.38 (m, 3H), 6.59 (d, J = 15.8 Hz, 1H), 5.72 (d, J = 15.4 Hz, 1H), 3.88–3.82 (m, 1H), 1.73 (s, 1H), 1.69 (dd, J = 14.0 and 8.7 Hz, 1H), 1.36 (dd, J = 14.0 and 3.0 Hz, 1H), 1.08 (d, J = 6.1 Hz, 3H), 1.00 (s, 3H), 0.98 (s, 3H), 0.45 (s, 3H, CH3Si), 0.43 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 160.9 (CH), 140.5 (C), 133.7 (CH), 128.8 (CH), 127.8 (CH), 124.6 (CH), 65.5 (CH), 52.7 (CH2), 38.5 (C), 29.1 (CH3), 27.3 (CH3), 24.9 (CH3), 0.6 (CH3), 0.5 (CH3); MS (CI): m/z 261 (M+ − 1), 247 (M+ − Me), 185 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C16H26NaOSi ([M + Na]+): 285.1645, found 285.1647.
(Z,2S*,4R*)-6-Dimethylphenylsilyl-4-phenyl-5-hexen-2-ol (2h). Colorless oil (44%); IR νmax(film)/cm−1 3412, 1605, 1250, 1118; 1H NMR (300 MHz, CDCl3) δ = 7.63–7.55 (m, 2H), 7.44–7.38 (m, 3H), 7.28–7.23 (m, 2H), 7.20–7.15 (m, 1H), 7.05–7.00 (m, 2H), 6.63 (dd, J = 14.0 and 10.5 Hz, 1H), 5.72 (d, J = 14.0 Hz, 1H), 3.63–3.55 (m, 1H), 3.49–3.39 (m, 1H), 1.83–1.71 (m, 1H), 1.69–1.53 (m, 1H), 1.28 (s, 1H), 1.01 (d, J = 6.1 Hz, 3H), 0.46 (s, 3H, CH3Si), 0.42 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 153.7 (CH), 143.7 (C), 139.9 (C), 134.1 (CH), 129.3 (CH), 128.8 (CH), 128.1 (CH), 127.5 (CH), 126.4 (CH), 65.7 (CH), 46.7 (CH), 46.3 (CH2), 24.1 (CH3), −0.6 (CH3), −0.9 (CH3); MS (CI): m/z 309 (M+ − 1), 295 (M+ − Me), 233 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C20H26NaOSi ([M + Na]+): 333.1645, found 333.1646.
(Z,2R*,4R*)-6-Dimethylphenylsilyl-4-phenyl-5-hexen-2-ol (3h). White solid m.p. 52.5 °C (44%); IR νmax(film)/cm−1 3412, 1605, 1250, 1118; 1H NMR (300 MHz, CDCl3) δ = 7.63–7.55 (m, 2H), 7.44–7.38 (m, 3H), 7.28–7.23 (m, 2H), 7.20–7.15 (m, 1H), 7.05–7.00 (m, 2H), 6.51 (dd, J = 14.0 and 10.5 Hz, 1H), 5.69 (d, J = 14.0 Hz, 1H), 3.61–3.49 (m, 2H), 1.94–1.81 (m, 1H), 1.71–1.61 (m, 1H), 1.30–1.21 (brs, 1H), 1.05 (t, J = 6.2 Hz, 3H), 0.51 (s, 6H, (CH3)2Si); 13C NMR (75 MHz, CDCl3) δ = 153.0 (CH), 144.1 (C), 139.6 (C), 134.0 (CH), 129.2 (CH), 128.6 (CH), 128.1 (CH), 127.2 (CH), 126.2 (CH), 65.7 (CH), 46.3 (CH2), 46.1 (CH), 23.4 (CH3), −0.6 (CH3), −1.1 (CH3); MS (CI): m/z 309 (M+ − 1), 295 (M+ − Me), 233 (M+ − Ph), 135 (SiMe2Ph).
(Z,2R*,4S*)-6-Dimethylphenylsilyl-4-isopropyl-5-hexen-2-ol (2i). Colorless oil (46%); IR νmax(film)/cm−1 3371, 1252, 1114; 1H NMR (300 MHz, CDCl3) δ = 7.59–7.55 (m, 2H), 7.37–7.35 (m, 3H), 6.17 (dd, J = 14.2 and 10.7 Hz, 1H), 5.72 (d, J = 14.2 Hz, 1H), 3.56–3.51 (m, 1H), 2.19–2.12 (m, 1H), 1.55–1.51 (m, 2H), 1.40 (ddd, J = 13.8, 9.6 and 3.2 Hz, 1H), 1.19 (ddd, J = 13.8, 10.5 and 2.7 Hz, 1H), 1.06 (d, J = 6.2 Hz, 3H), 0.82 (d, J = 6.8 Hz, 3H), 0.81 (d, J = 6.8 Hz, 3H), 0.45 (s, 3H), 0.39 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 153.6 (CH), 140.3 (C), 134.1 (CH), 129.4 (CH), 128.4 (CH), 128.3 (CH), 65.9 (CH), 45.4 (CH), 41.4 (CH2), 32.9 (CH), 24.6 (CH3), 20.1 (CH3), 19.7 (CH3), −0.1 (CH3), −0.6 (CH3); MS (CI): m/z 276 (M+), 275 (M+ − 1), 261 (M+ − Me), 259 (M+ − OH), 244 (M+iPr), 199 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C17H28NaOSi ([M + Na]+): 299.1805, found 299.1804.
(Z,2S*,4S*)-6-Dimethylphenylsilyl-4-isopropyl-5-hexen-2-ol (3i). Colorless oil (46%); IR νmax(film)/cm−1 3383, 1252, 1113; 1H NMR (300 MHz, CDCl3) δ = 7.57–7.54 (m, 2H), 7.37–7.35 (m, 3H), 6.35 (dd, J = 14.2 and 10.7 Hz, 1H), 5.73 (d, J = 14.2 Hz, 1H), 3.61–3.57 (m, 1H), 2.09–2.04 (m, 1H), 1.58–1.51 (m, 2H), 1.46 (dt, J = 13.8 and 4.6 Hz, 1H), 1.33–1.25 (m, 1H), 1.02 (d, J = 6.2 Hz, 3H), 0.80 (d, J = 6.8 Hz, 3H), 0.75 (d, J = 6.8 Hz, 3H), 0.43 (s, 3H), 0.40 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 153.9 (CH), 139.5 (C), 133.8 (CH), 129.0 (CH), 128.2 (CH), 127.8 (CH), 67.4 (CH), 46.5 (CH), 41.4 (CH2), 31.9 (CH), 23.6 (CH3), 19.6 (CH3), 19.1 (CH3), −0.6 (CH3), −0.9 (CH3).
(E)-5-Dimethylphenylsilyl-3,4-diphenyl-4-penten-1-ol (2j). Colorless oil (89%); IR νmax(film)/cm−1 3474, 1565, 1252, 1113; 1H NMR (300 MHz, CDCl3) δ = 7.71–7.68 (m, 2H), 7.45–7.44 (m, 3H), 7.27–7.15 (m, 7H), 7.08–7.05 (m, 1H), 6.88–6.85 (m, 2H), 5.89 (s, 1H), 4.13 (t, J = 7.9 Hz, 1H), 3.38–3.37 (m, 2H), 2.21–2.11 (m, 1H), 1.87–1.73 (m, 1H), 0.95 (s, 1H), 0.58 (s, 3H), 0.56 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 161.7 (C), 143.4 (C), 141.7 (C), 139.9 (C), 134.2 (CH), 130.4 (CH), 129.5 (CH), 128.4 (CH), 128.3 (CH), 128.3 (CH), 127.7 (CH), 127.1 (CH), 126.5 (CH), 61.1 (CH2), 47.2 (CH), 35.1 (CH2), −0.3 (CH3), −0.8 (CH3); MS (CI) m/z (%): 373 (M+ + 1), 372 (M+), 357 (M+ − Me), 355 (M+ − OH), 295 (M+ − Ph), 237 (M+ − PhMe2Si), 135 (PhMe2Si).
(E,1R*,3S*)-5-Dimethylphenylsilyl-1,3,4-triphenyl-4-penten-1-ol (2k). White solid m.p. = 101–102 °C (45%); IR νmax(film)/cm−1 3476, 1551, 1259, 1106; 1H NMR (300 MHz, CDCl3) δ = 7.74–6.72 (m, 20H), 5.64 (s, 1H), 4.40–4.30 (m, 2H), 2.29–2.22 (m, 1H), 2.06–1.99 (m, 1H), 1.30 (brs, 1H, OH), 0.56 (s, 3H, CH3Si), 0.55 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 163.2 (C), 145.2 (C), 143.9 (C), 140.7 (C), 140.1 (C), 134.4 (CH), 129.3 (CH), 129.1 (CH), 128.8 (CH), 128.6 (CH), 128.5 (CH), 128.2 (CH), 128.1 (CH), 127.6 (CH), 127.4 (CH), 126.7 (CH), 126.5 (CH), 125.8 (CH), 71.90 (CH), 48.4 (CH), 42.5 (CH2), −0.6 (CH3), −0.7 (CH3).
(E,1S*,3S*)-5-Dimethylphenylsilyl-1,3,4-triphenyl-4-penten-1-ol (3k). White solid m.p. = 77–78 °C (45%); IR νmax(film)/cm−1 3476, 1551, 1259, 1106; 1H NMR (300 MHz, CDCl3) δ = 7.59–6.88 (m, 20H), 5.95 (brs, 1H), 4.47 (dd, J = 7.5 and 4.1 Hz, 1H), 4.21 (dd, J = 7.2 and 6.2 Hz, 1H), 2.32–2.28 (m, 1H), 2.03–1.97 (m, 1H), 1.43 (brs, 1H, OH), 0.43 (s, 3H, CH3Si), 0.42 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 160.9 (C), 145.1 (C), 143.6 (C), 141.9 (C), 140.1 (C), 134.0 (CH), 131.3 (CH), 129.3 (CH), 128.5 (CH), 128.4 (CH), 128.3 (CH), 128.2 (CH), 128.1 (CH), 127.7 (CH), 127.5 (CH), 127.1 (CH), 126.4 (CH), 125.7 (CH), 72.0 (CH), 47.2 (CH), 42.1 (CH2), −0.5 (CH3), −1.0 (CH3).

Synthesis of tetrahydrofurans 4, 5 using mercury salts

To a suspension of the mercury salt (1.09 mmol) and CaCO3 (2.17 mmol) in 9 ml of dry THF was added a solution of the vinylsilyl alcohol (1 mmol) in dry THF (1 ml). The mixture was stirred at room temperature (Tables 2 and 3) and then NaBH4 (0.72 mmol) in a 2.5 M solution of NaOH (4 ml) was added dropwise at 0 °C. The reaction mixture was vigorously stirred at 0 °C for l hour and then saturated NaCl solution was added (4 ml). The aqueous layer was extracted with ether and the combined extracts were washed with brine, dried over MgSO4 and evaporated in vacuo to give an oil which was purified by chromatography (EtOAc/hexane 1[thin space (1/6-em)]:[thin space (1/6-em)]20).

Synthesis of tetrahydrofurans 4–7 using acid catalysis

To a solution of the vinylsilyl alcohol (1 mmol) in CH2Cl2 (5 ml) was added p-TsOH (1 mmol) in CH2Cl2 (0.5 ml) at room temperature. The mixture was stirred at the shown conditions (Table 3) and quenched with saturated solution of NaHCO3 (5 ml). The organic layer was washed 3 times with NaHCO3, dried over MgSO4, evaporated in vacuo and purified by flash chromatography (EtOAc/hexane 1[thin space (1/6-em)]:[thin space (1/6-em)]20). The relative stereochemistry of all tetrahydrofurans was assigned on the basis of NOE experiments. The spectroscopic data of tetrahydrofuran 4d has been previously described.9b
2-Dimethylphenylsilylmethyl-tetrahydrofuran (4a). Colorless oil (92%); IR νmax(film)/cm−1 1245, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.59–7.55 (m, 2H), 7.43–7.35 (m, 3H), 3.97–3.85 (m, 2H), 3.71–3.63 (m, 1H), 1.94–1.80 (m, 3H), 1.45–1.32 (m, 2H), 1.11 (dd, J = 14.0 y 8.3 Hz, 1H), 0.37 (s, 6H, (CH3)2Si); 13C NMR (75 MHz, CDCl3) δ = 139.1 (C), 133.5 (CH), 128.9 (CH), 127.7 (CH), 77.1 (CH), 66.9 (CH2), 33.8 (CH2), 25.9 (CH2), 23.4 (CH2), −2.1 (CH3), −2.4 (CH3); MS (CI): m/z 219 (M+ − 1), 205 (M+ − Me), 143 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C13H20NaOSi ([M + Na]+): 243.1176, found 243.1173.
(2R*,3R*)-2-Dimethylphenylsilylmethyl-3-methyl-tetrahydrofuran (4b). Colorless oil (90%); IR νmax(film)/cm−1 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.63–7.58 (m, 2H), 7.46–7.39 (m, 3H), 3.92–3.85 (m, 1H), 3.82–3.75 (m, 1H), 3.51–3.44 (m, 1H), 2.17–2.05 (m, 1H), 1.83–1.73 (m, 1H), 1.58–1.45 (m, 1H), 1.21 (dd, J = 14.5 and 4.6 Hz, 1H), 1.06 (dd, J = 14.5 and 8.8 Hz, 1H), 1.01 (d, J = 6.6 Hz, 3H), 0.41 (s, 6H, (CH3)2Si); 13C NMR (75 MHz, CDCl3) δ = 139.8 (C), 133.6 (CH), 128.7 (CH), 127.7 (CH), 83.6 (CH), 66.2 (CH2), 42.1 (CH), 34.2 (CH2), 21.5 (CH2), 17.0 (CH3), −1.7 (CH3), −2.4 (CH3); MS (CI): m/z 233 (M+ − 1), 213 (M+ − Me), 157 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C14H22NaOSi ([M + Na]+): 257.1332, found 257.1333.
(2R*,3R*)-2-Dimethylphenylsilylmethyl-3-propyl-tetrahydrofuran (4c). Colorless oil (80%); IR νmax(film)/cm−1 1252, 1113; 1H NMR (300 MHz, CDCl3) δ = 7.61–7.55 (m, 2H), 7.42–7.35 (m, 3H), 3.87–3.79 (m, 1H), 3.80–3.71 (m, 1H), 3.56–3.49 (m, 1H), 2.12–2.00 (m, 1H), 1.71–1.61 (m, 1H), 1.53–1.39 (m, 1H), 1.38–1.24 (m, 3H), 1.21–1.13 (m, 2H), 1.04 (dd, J = 14.5 y 8.8 Hz, 1H), 0.89 (t, J = 7.0 Hz, 3H), 0.36 (s, 3H, CH3Si), 0.35 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 139.8 (C), 133.6 (CH), 128.7 (CH), 127.6 (CH), 82.3 (CH), 66.3 (CH2), 47.5 (CH), 35.0 (CH2), 32.2 (CH2), 22.2 (CH2), 21.5 (CH2), 14.2 (CH3), −1.7 (CH3), −2.5 (CH3); MS (CI): m/z 261 (M+ − 1), 247 (M+ − Me), 185 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C16H26NaOSi ([M + Na]+): 285.1645, found 285.1643.
(2R*,5S*)-2-Dimethylphenylsilylmethyl-5-methyl-tetrahydrofuran (4e). Colorless oil (71%); IR νmax(film)/cm−1 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.60–7.52 (m, 2H), 7.37–7.34 (m, 3H), 4.17–4.06 (m, 2H), 2.07–1.88 (m, 2H), 1.51–1.33 (m, 3H), 1.18 (d, J = 6.1 Hz, 3H), 1.06 (dd, J = 14.2 and 9.0 Hz, 1H), 0.33 (s, 6H, (CH3)2Si); 13C NMR (75 MHz, CDCl3) δ = 139.1 (C), 133.5 (CH), 128.8 (CH), 127.7 (CH), 76.2 (CH), 73.6 (CH), 34.9 (CH2), 34.5 (CH2), 24.0 (CH2), 21.5 (CH3), −2.2 (CH3), −2.4 (CH3); MS (CI): m/z 233 (M+ − 1), 219 (M+ − Me), 157 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C14H22NaOSi ([M + Na]+): 257.1332, found 257.1331.
(2S*,5S*)-2-Dimethylphenylsilylmethyl-5-methyl-tetrahydrofuran (5e). Colorless oil (9%); IR νmax(film)/cm−1 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.60–7.52 (m, 2H), 7.40–7.34 (m, 3H), 3.92–3.82 (m, 2H), 1.98–1.86 (m, 2H), 1.48–1.36 (m, 3H), 1.23 (d, J = 6.1 Hz, 3H), 1.08 (dd, J = 14.0 and 9.2 Hz, 1H), 0.32 (s, 6H, (CH3)2Si); 13C NMR (75 MHz, CDCl3) δ = 139.1 (C), 133.5 (CH), 128.8 (CH), 127.7 (CH), 77.2 (CH), 74.4 (CH), 33.6 (CH2), 33.2 (CH2), 24.0 (CH2), 21.4 (CH3), −2.1 (CH3), −2.3 (CH3); MS (CI): m/z 233 (M+ − 1), 219 (M+ − Me), 157 (M+ − Ph), 135 (SiMe2Ph).
(2R*,5S*)-2-Dimethylphenylsilylmethyl-5-ethyl-tetrahydrofuran (4f). Colorless oil (63%); IR νmax(film)/cm−1 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.60–7.54 (m, 2H), 7.41–7.36 (m, 3H), 4.12–4.03 (m, 1H), 3.92–3.83 (m, 1H), 2.06–1.91 (m, 2H), 1.63–1.32 (m, 5H), 1.07 (dd, J = 14.0 y 8.3 Hz, 1H), 0.93 (t, J = 7.5 Hz, 3H), 0.35 (s, 3H, CH3Si), 0.34 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 139.3 (C), 133.5 (CH), 128.8 (CH), 127.7 (CH), 79.3 (CH), 76.2 (CH), 34.9 (CH2), 32.1 (CH2), 29.0 (CH2), 23.9 (CH2), 10.4 (CH3), −2.1 (CH3),−2.4 (CH3); MS (CI): m/z 247 (M+ − 1), 233 (M+ − Me), 171 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C15H24NaOSi ([M + Na]+): 271.1489, found 271.1488.
(2S*,5S*)-2-Dimethylphenylsilylmethyl-5-ethyl-tetrahydrofuran (5f). Colorless oil (24%); IR νmax(film)/cm−1 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.61–7.53 (m, 2H), 7.39–7.32 (m, 3H), 3.95–3.85 (m, 1H), 3.70–3.64 (m, 1H), 1.91–1.86 (m, 2H), 1.63–1.35 (m, 4H), 1.37 (dd, J = 14.5 and 5.7 Hz, 1H), 1.08 (dd, J = 14.5 and 8.6 Hz, 1H), 0.93 (t, J = 7.5 Hz, 3H), 0.34 (s, 3H, CH3Si), 0.33 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 139.3 (C), 133.5 (CH), 128.8 (CH), 127.6 (CH), 80.0 (CH), 76.9 (CH), 33.6 (CH2), 31.0 (CH2), 29.0 (CH2), 23.9 (CH2), 10.4 (CH3), −2.1 (CH3), −2.3 (CH3); MS (CI): m/z 247 (M+ − 1), 233 (M+ − Me), 171 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C15H24NaOSi ([M + Na]+): 271.1489, found 271.1488.
(2R*,5S*)-2-Dimethylphenylsilylmethyl-3,3,5-trimethyl-tetrahydrofuran (4g). Colorless oil (76%); IR νmax(film)/cm−1 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.62–7.57 (m, 2H), 7.37–7.27 (m, 3H), 4.16–4.09 (m, 1H), 3.57 (dd, J = 10.5 and 3.1 Hz, 1H), 1.86 (dd, J = 12.1 and 6.8 Hz, 1H), 1.31 (dd J = 12.1 and 8.5 Hz, 1H), 1.17 (d, J = 6.1 Hz, 3H), 0.95–0.80 (m, 2H), 0.92 (s, 3H), 0.88 (s, 3H), 0.37 (s, 3H, CH3Si), 0.35 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 139.9 (C), 133.7 (CH), 128.6 (CH), 127.5 (CH), 82.9 (CH), 71.5 (CH), 49.1 (CH2), 42.5 (C), 24.9 (CH3), 22.4 (CH3), 21.2 (CH3), 15.4 (CH2), −1.8 (CH3), −2.8 (CH3); MS (CI): m/z 261 (M+ − 1), 247 (M+ − Me), 185 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C16H26NaOSi ([M + Na]+): 285.1645, found 285.1648.
(2S*,5S*)-2-Dimethylphenylsilylmethyl-3,3,5-trimethyl-tetrahydrofuran (5g). Colorless oil (14%); IR νmax(film)/cm−1 1249, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.65–7.61 (m, 2H), 7.42–7.38 (m, 3H), 4.03–3.93 (m, 1H), 3.52 (dd, J = 11.5 and 2.7 Hz, 1H), 1.84 (dd, J = 12.3 and 7.8 Hz, 1H), 1.37 (dd, J = 12.3 and 7.4 Hz, 1H), 1.27 (d, J = 6.1 Hz, 3H), 1.03–0.95 (m, 1H), 0.99 (s, 3H), 0.96 (s, 3H), 0.85 (dd, J = 14.5 and 2.7 Hz, 1H), 0.42 (s, 3H, CH3Si), 0.41 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 140.1 (C), 133.8 (CH), 128.7 (CH), 127.7 (CH), 85.2 (CH), 72.5 (CH), 48.4 (CH2), 41.9 (C), 26.5 (CH3), 24.3 (CH3), 22.5 (CH3), 17.0 (CH2), −1.4 (CH3), −2.5 (CH3); MS (CI): m/z 261 (M+ − 1), 247 (M+ − Me), 185 (M+ − Ph), 135 (SiMe2Ph).
(2R*,3S*,5S*)-2-Dimethylphenylsilylmethyl-5-methyl-3-phenyltetrahydrofuran (4h). Colorless oil (92%); IR νmax(film)/cm−1 1252, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.52–7.49 (m, 2H), 7.38–7.27 (m, 3H), 7.25–7.17 (m, 5H), 4.31–4.23 (m, 1H), 4.14–4.07 (m, 1H), 2.98–2.89 (m, 1H), 2.50–2.41 (m, 1H), 1.79–1.62 (m, 1H), 1.37–1.31 (m, 1H), 1.33 (d, J = 6.1 Hz, 3H), 1.13–1.10 (m, 1H), 0.32 (s, 3H, CH3Si), 0.30 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 141.7 (C), 139.7 (C), 133.6 (CH), 132.9 (CH), 128.6 (CH), 128.5 (CH), 127.6 (CH), 126.4 (CH), 82.6 (CH), 73.7 (CH), 55.7 (CH), 43.9 (CH2), 21.7 (CH3), 21.6 (CH2), −1.8 (CH3), −2.5 (CH3); MS (CI): m/z 309 (M+ − 1), 295 (M+ − Me), 233 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C20H26NaOSi ([M + Na]+): 333.1645, found 333.1639.
(2R*,3S*,5R*)-2-Dimethylphenylsilylmethyl-5-methyl-3-phenyltetrahydrofuran (6h). Colorless oil (91%); IR νmax(film)/cm−1 1252, 1109; 1H NMR (300 MHz, CDCl3) δ = 7.62–7.59 (m, 2H), 7.44–7.37 (m, 5H), 7.33–7.28 (m, 3H), 4.39–4.30 (m, 1H), 4.07–4.01 (m, 1H), 3.04–2.96 (m, 1H), 2.29–2.19 (m, 1H), 2.13–2.03 (m, 1H), 1.41 (d, J = 6.1 Hz, 3H), 1.24–1.22 (m, 2H), 0.44 (s, 3H, CH3Si), 0.41 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 142.5 (C), 139.8 (C), 133.7 (CH), 128.5 (CH), 127.8 (CH), 127.7 (CH), 126.4 (CH), 84.5 (CH), 74.4 (CH), 54.2 (CH), 42.6 (CH2), 22.2 (CH3), 21.6 (CH2), −1.5 (CH3), −2.3 (CH3); MS (CI): m/z 309 (M+ − 1), 295 (M+ − Me), 233 (M+ − Ph), 135 (SiMe2Ph); HRMS (ESI+) m/z calcd for C20H26NaOSi ([M + Na]+): 333.1645, found 333.1641.
(2R*,3S*,5S*)-2-Dimethylphenylsilylmethyl-3-isopropyl-5-methyltetrahydrofuran (4i). Colorless oil (90%); 1H NMR (300 MHz, CDCl3) δ = 7.62–7.44 (m, 2H), 7.42–7.28 (m, 3H), 4.04–3.78 (m, 2H), 2.02–1.92 (m, 1H), 1.66–1.42 (m, 2H), 1.15 (d, J = 6.0 Hz, 3H), 1.15–1.09 (m, 2H), 1.05 (dd, J = 14.7 and 4.4 Hz, 1H), 0.83 (d, J = 6.6 Hz, 3H), 0.81 (d, J = 6.6 Hz, 3H), 0.33 (s, 3H, CH3Si), 0.32 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 140.2 (C), 133.7 (CH), 128.7 (CH), 127.7 (CH), 79.6 (CH), 73.1 (CH), 56.7 (CH), 38.5 (CH2), 31.1 (CH), 24.7 (CH2), 22.1 (CH3), 21.0 (CH3), 20.0 (CH3), −1.6 (CH3), −2.3 (CH3); HRMS (ESI+) m/z calcd for C17H28NaOSi ([M + Na]+): 299.1802, found 299.1804.
(2R*,3S*,5R*)-2-Dimethylphenylsilylmethyl-3-isopropyl-5-methyltetrahydrofuran (6i). Colorless oil (89%); 1H NMR (300 MHz, CDCl3) δ = 7.61–7.46 (m, 2H), 7.43–7.27 (m, 3H), 3.93–3.78 (m, 1H), 3.75–3.55 (m, 1H), 1.80–1.65 (m, 1H), 1.63–1.39 (m, 3H), 1.17 (d, J = 6.1 Hz, 3H), 1.19–1.14 (m, 1H), 1.07 (dd, J = 14.6, 8.7 Hz, 1H), 0.83 (d, J = 6.5 Hz, 3H), 0.81 (d, J = 6.5 Hz, 3H), 0.33 (s, 3H, CH3Si), 0.32 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 140.3 (C), 133.8 (CH), 128.7 (CH), 127.7 (CH), 80.5 (CH), 74.1 (CH), 54.3, (CH) 36.7 (CH2), 29.9 (CH), 24.3 (CH2), 21.9 (CH3), 19.8 (CH3), −1.3 (CH3), −2.1 (CH3); HRMS (ESI+) m/z calcd for C17H28NaOSi ([M + Na]+): 299.1802, found 299.1805.
(2S*,3S*)-2-Dimethylphenylsilylmethyl-2,3-diphenyl-tetrahydrofuran (4j) and (2R*,3S*)-2-dimethylphenylsilyl-methyl-2,3-diphenyltetrahydrofuran (5j). Colorless oil (86%, 55[thin space (1/6-em)]:[thin space (1/6-em)]45 mixture of 4j and 5j); 4j: 1H NMR (300 MHz, CDCl3) δ = 7.50–6.67 (m, 15H), 4.40–4.30 (m, 1H), 4.10–4.04 (m, 1H), 3.36 (dd, J = 10 and 8.1 Hz, 1H), 2.21–2.13 (m, 2H), 1.76 (d, J = 14.7 Hz, 1H), 1.72 (d, J = 14.7 Hz, 1H), 0.30 (s, 3H, CH3Si), 0.15 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 145.4 (C), 140.9 (C), 139.1 (C), 133.4 (CH), 128.9 (CH), 128.4 (CH), 128.3 (CH), 127.4 (CH), 127.2 (CH), 126.5 (CH), 126.3 (CH), 125.6 (CH), 88.5 (C), 66.0 (CH2), 58.6 (CH), 31.0 (CH2), 30.5 (CH2), −1.3 (CH3), −1.8 (CH3); 5j: 1H NMR (300 MHz, CDCl3) δ = 7.50–6.67 (m, 15H), 4.15–4.09 (m, 2H), 3.29 (dd, J = 9.2 and 7.4 Hz, 1H), 2.43–2.36 (m, 1H), 2.27–2.20 (m, 1H), 1.37 (d, J = 15 Hz, 1H), 1.07 (d, J = 15 Hz, 1H), −0.19 (s, 3H, CH3Si), −0.11 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 145.4 (C), 140.9 (C), 139.1 (C), 133.4 (CH), 128.9 (CH), 128.4 (CH), 128.3 (CH), 127.4 (CH), 127.2 (CH), 126.5 (CH), 126.3 (CH), 125.6 (CH), 89.2 (C), 66.4 (CH2), 58.7 (CH), 32.1 (CH2), 24.5 (CH2), −1.3 (CH3), −1.8 (CH3).
(2S*,3S*,5R*)-2-Dimethylphenylsilylmethyl-2,3,5-triphenyltetrahydrofuran (4k) and (2R*,3S*,5R*)-2-dimethylphenylsilylmethyl-2,3,5-triphenyltetrahydrofuran (5k). Colorless oil (85%, 57[thin space (1/6-em)]:[thin space (1/6-em)]43 mixture of 4k and 5k); 4k: 1H NMR (300 MHz, CDCl3) δ = 7.57–6.72 (m, 20H), 5.29 (dd, J = 10.9 and 5.0 Hz, 1H), 3.70 (dd, J = 12.1 and 5.9 Hz, 1H), 2.57–2.50 (m, 1H), 2.25 (ddd, J = 12.1, 12.0 and 10.9 Hz, 1H), 1.96 (d, J = 14.6 Hz, 1H), 1.87 (d, J = 14.6 Hz, 1H), 0.28 (s, 3H, CH3Si), −0.10 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 145.2 (C), 143.9 (C), 140.7 (C), 140.1 (C), 134.3 (CH), 133.6 (CH), 129.3 (CH), 128.8 (CH), 128.6 (CH), 127.7 (CH), 127.3 (CH), 126.8 (CH), 126.4 (CH), 126.1 (CH), 125.8 (CH), 90.0 (C), 78.1 (CH), 61.3 (CH), 38.7 (CH2), 31.8 (CH2), −1.0 (CH3), −1.6 (CH3); 5k: 1H NMR (300 MHz, CDCl3) δ = 7.57–6.72 (m, 20H), 5.24 (dd, J = 10.9 and 4.9 Hz, 1H), 3.61 (dd, J = 12.1 and 6.4 Hz, 1H), 2.57–2.50 (m, 1H), 2.39 (ddd, J = 12.1, 12.0 and 10.9 Hz, 1H), 1.51 (d, J = 14.5 Hz, 1H), 1.04 (d, J = 14.5 Hz, 1H), 0.11 (s, 3H, CH3Si), −0.24 (s, 3H, CH3Si); 13C NMR (75 MHz, CDCl3) δ = 145.2 (C), 143.9 (C), 140.7 (C), 140.1 (C), 134.3 (CH), 133.6 (CH), 129.3 (CH), 128.8 (CH), 128.6 (CH), 127.7 (CH), 127.3 (CH), 126.8 (CH), 126.4 (CH), 126.1 (CH), 125.8 (CH), 88.5 (C), 79.9 (CH), 59.9 (CH), 42.2 (CH2), 27.5 (CH2), −0.9 (CH3), −1.3 (CH3).
(2S*,3S*,5S*)-2-Dimethylphenylsilylmethyl-2,3,5-triphenyltetrahydrofuran (6k) and (2R*,3S*,5S*)-2-dimethylphenylsilylmethyl-2,3,5-triphenyltetrahydrofuran (7k). Colorless oil (82%, mixture of 6k and 7k); 6k: 1H NMR (300 MHz, CDCl3) δ = 7.51–6.71 (m, 20H), 5.64 (d, J = 9.0 Hz, 1H), 3.43–3.38 (m, 1H), 2.71–2.62 (m, 1H), 2.12–2.07 (m, 1H), 1.95 (d, J = 14.5 Hz, 1H), 1.75 (d, J = 14.5 Hz, 1H), 0.27 (CH3), −0.26 (CH3); 13C NMR (75 MHz, CDCl3) δ = 145.49 (C), 142.82 (C), 140.99 (C), 137.69 (C), 133.62 (CH), 129.13 (CH), 128.59 (CH), 128.29 (CH), 127.80 (CH), 127.55 (CH), 127.07 (CH), 126.95 (CH), 126.62 (CH), 125.52 (CH), 90.94, (C), 78.13 (CH), 58.68 (CH), 38.17 (CH2), 30.90 (CH2), −0.96 (CH3), −1.89 (CH3); 7k: 1H NMR (300 MHz, CDCl3) δ = 7.49–6.71 (m, 20H), 5.10 (dd, J = 9.3, 4.5 Hz, 1H), 3.38 (dd, J = 11.4 and 8.7 Hz, 1H), 3.02–2.93 (m, 1H), 2.33 (ddd, J = 13.1, 8.7 and 4.5 Hz, 1H), 1.75 (d, J = 14.5 Hz, 1H), 1.18 (d, J = 14.5 Hz, 1H), 0.16 (CH3), −0.18 (CH3); 13C NMR (75 MHz, CDCl3) δ = 146.18 (C), 144.63 (C), 140.99 (C), 138.16 (C), 133.64 (CH), 129.69 (CH), 128.56 (CH), 127.99 (CH), 127.78 (CH), 127.70 (CH), 127.37 (CH), 126.39 (CH), 125.65 (CH), 89.36 (C), 77.17 (CH), 57.13 (CH), 40.04 (CH2), 22.21 (CH2), −1.47 (CH3), −1.69 (CH3).

Acknowledgements

We thank the Ministry of Education, Culture and Sport (MECD) of Spain (CTQ2009-09302) and the “Junta de Castilla y León” (GR170) for financial support. H.B. and A.D.-V. wish to thank the MECD and “Junta de Castilla y León” for doctorate grants. We are grateful to Dr Gabriel Aullón for his help with computational studies. Allocation of computer facilities at IQTCUB is also acknowledged.

Notes and references

  1. A. Lorente, J. Lamariano-Merketegi, F. Albericio and M. Álvarez, Chem. Rev., 2013, 113, 4567–4610 CrossRef CAS PubMed.
  2. H. Gerlach, R. Hutter, W. Keller-Schlierlein, J. Seibl and H. Zahner, Helv. Chim. Acta, 1967, 50, 1782–1793 CrossRef CAS PubMed.
  3. T. Rezanka, L. O. Hanus and V. M. Dembitsky, Eur. J. Org. Chem., 2003, 20, 4073 CrossRef PubMed.
  4. Y. Takahashi, T. Kubota and J. Kobayashi, J. Antibiot., 2007, 60, 376 CrossRef CAS PubMed.
  5. (a) R. T. Williamson, A. Boulanger, A. Vulpanovici, M. A. Roberts and W. H. Gerwick, J. Org. Chem., 2002, 67, 7927 CrossRef CAS PubMed; (b) R. T. Williamson, A. Boulanger, A. Vulpanovici, M. A. Roberts and W. H. Gerwick, J. Org. Chem., 2003, 68, 2060 CrossRef CAS.
  6. (a) F. Freeman and K. D. Robarge, Tetrahedron Lett., 1985, 26, 1943–1946 CrossRef CAS; (b) Y. Tamaru, M. Hojo, S. Kawamura, S. Sawada and Z. Yoshida, J. Org. Chem., 1987, 52, 4062–4072 CrossRef CAS.
  7. (a) O. Andrey, L. Ducry, Y. Landais, D. Planchenault and V. Weber, Tetrahedron, 1997, 53, 4339–4352 CrossRef CAS; (b) Y. Landais, D. Planchenault and V. Weber, Tetrahedron Lett., 1995, 36, 2987–2990 CrossRef CAS; (c) Y. Landais and D. Planchenault, Synlett, 1995, 1191–1193 CrossRef CAS PubMed.
  8. (a) O. Andrey, C. Glanzmann, Y. Landais and L. Parra-Rapado, Tetrahedron, 1997, 53, 2835–2854 CrossRef CAS; (b) A. Garavelas, I. Mavropoulos, P. Perlmutter and G. Westman, Tetrahedron Lett., 1995, 36, 463–466 CrossRef CAS.
  9. (a) K. Miura, T. Hondo, S. Okajima and A. Hosomi, Tetrahedron Lett., 1996, 37, 487–490 CrossRef CAS; (b) K. Miura, S. Okajima, T. Hondo, T. Nakagawa, T. Takahashi and A. Hosomi, J. Am. Chem. Soc., 2000, 122, 11348–11357 CrossRef CAS; (c) K. Miura and A. Hosomi, Synlett, 2003, 143–155 CAS.
  10. (a) F. J. Pulido and A. Barbero, Synthesis, 2004, 779–785 CrossRef PubMed; (b) A. Barbero, P. Castreño and F. J. Pulido, J. Am. Chem. Soc., 2005, 127, 8022–8023 CrossRef CAS PubMed; (c) A. Barbero, Y. Blanco and F. J. Pulido, Chem. Commun., 2001, 1606–1607 RSC; (d) A. Barbero, Y. Blanco and F. J. Pulido, J. Org. Chem., 2005, 70, 6876–6883 CrossRef CAS PubMed.
  11. (a) F. J. Pulido, A. Barbero and R. Abad, Eur. J. Org. Chem., 2011, 6974–6979 CrossRef CAS PubMed; (b) A. Barbero, A. Diez-Varga and F. J. Pulido, Org. Lett., 2013, 15, 5234–5237 CrossRef CAS PubMed; (c) A. Diez-Varga, H. Barbero, F. J. Pulido, A. González-Ortega and A. Barbero, Chem.–Eur. J., 2014, 20, 14112–14119 CrossRef CAS PubMed.
  12. F. J. Pulido, A. Barbero, P. Val, A. Diez and A. González-Ortega, Eur. J. Org. Chem., 2012, 5350–5356 CrossRef CAS PubMed.
  13. K. Miura, T. Hondo, H. Saito, H. Ito and A. Hosomi, J. Org. Chem., 1997, 62, 8292–8293 CrossRef CAS.
  14. R. L. Danheiser, T. Talcaheshi, B. Bertok and B. R. Dixon, Tetrahedron Lett., 1993, 34, 3845–3848 CrossRef CAS.
  15. M. N. Paddon-Row, N. G. Rondan and K. N. Houk, J. Am. Chem. Soc., 1982, 104, 7162–7166 CrossRef CAS.
  16. (a) I. Fleming, Pure Appl. Chem., 1988, 60, 71–78 CrossRef CAS; (b) I. Fleming, Stereocontrol in Organic Synthesis using silicon compounds, in Frontiers in Natural Product Chemistry, ed. A. Attur-ur-Rahman, I. Choudary and K. M. Kahn, Bentham, Bentham Scientific Publishers, 2005, pp. 55–64 Search PubMed; (c) I. Fleming, A. Barbero and D. Walter, Chem. Rev., 1997, 97, 2063–2192 CrossRef CAS PubMed.
  17. See ESI for details about level of theory procedure followed.
  18. Several attempts to optimize I in a conformation similar to that in II with and without restrictions were carried out and none of them resulted in a lower minimum than the one discussed.

Footnote

Electronic supplementary information (ESI) available: Computational details as well as copies of 1H and 13C NMR spectra for all new compounds are provided. See DOI: 10.1039/c5ra06640a

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.